NEW YORK, March 27, 2015 /PRNewswire/ -- Levi & Korsinsky announces it has commenced an investigation of Ohr Pharmaceutical, Inc. (NASDAQ: OHRP) concerning possible violations of federal securities laws. The investigation concerns certain statements issued by the Company in connection with its study of the drug OHR-102. To obtain additional information, GO TO: http://zlk.9nl.com/ohr-pharmaceutical-ohrpor contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:   
Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004           
Tel: (212) 363-7500
Toll Free:  (877) 363-5972
Fax: (866) 367-6510
www.zlk.com

Logo - http://photos.prnewswire.com/prnh/20120409/MM84375LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-levi--korsinsky-llp-announces-an-investigation-involving-possible-violations-of-federal-securities-laws-by-the-board-of-ohr-pharmaceutical-inc----ohrp-300057199.html

SOURCE Levi & Korsinsky, LLP